The DOI matches its Crossref record; 1,273 of the 1,273 references it cites were found in a registry or an index.
The c‐myc Promoter: Still MysterY and Challenge
Abstract
The transcription factor c-Myc is a key regulator of cell proliferation, cell growth, differentiation, and apoptosis. Deregulated c-myc expression possesses a high transformation potential and the proto-oncogene c-myc represents a promising target in anticancer therapy. This review on the c-myc promoter describes its organization, the different levels of its normal regulation (including initiation and elongation of transcription, the dual P1/P2 promoters, chromatin structure, c-Myc autosuppression) as well as its deregulation in Burkitt's lymphoma. Furthermore, it summarizes the many different transcription factors, signal transduction pathways, and feedback loops that activate or repress c-myc transcription. Finally, a concept for regulation of the c-myc promoter in different biological settings, for example, immediate-early induction, constant expression throughout the cell cycle in continuously cycling cells, repression during terminal differentiation and deregulation in cancer, is formulated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, β-catenin has been shown to stimulate c-Myc expression by activating the c-Myc promoter, which comprises multiple T cell factor-4 (TCF-4) binding sites.447”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [447]
Citations
Cites
3 retracted
Items 1,201–1,273 of 1,273
Regulation of c-myc transcription in vitro: dependence on the guanine-rich promoter element ME1a1.
Dj, H. (1990) · PubMed · Cited by 23
Ghosh, A. K., Steele, R., & Ray, R. B. (2005) · Cancer Research · doi:10.1158/0008-5472.718.65.3 · Cited by 22
Simpson, R. U., O’Connell, T. D., Pan, Q., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19587 · Cited by 22
Wang, Z., Ge, L., Wang, M., & Carr, B. I. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20649 · Cited by 22
Mautner, J., Behrends, U., Hörtnagel, K., et al. (1996) · PubMed · Cited by 22
Salehi, Z., Taylor, J. D., & Niedel, J. E. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77962-9 · Cited by 21
Regulation of Cellular Genes in a Chromosomal Context by the Retinoblastoma Tumor Suppressor Protein
Buchmann, A. M., Swaminathan, S., & Thimmapaya, B. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4565 · Cited by 21
Mincione, G., Bianco, C., Kannan, S., Colletta, G., Ciardiello, F., Sliwkowski, M. X., Yarden, Y., Normanno, N., Pramaggiore, A., Kim, N., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960315)60:4 · Cited by 21
Ishida, S., Shudo, K., Takada, S., et al. (1995) · PubMed · Cited by 21
Batsché, É., Lipp, M., & Crémisi, C. (1994) · PubMed · Cited by 20
?-amyloid protein induces the formation of purine dimers in cellular DNA
Duker, N. J., Sperling, J. M., Soprano, K. J., Druin, D. P., Davis, A., & Ashworth, R. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010601)81:3 · Cited by 20
Wittekindt, N. E. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.3.800 · Cited by 20
MBP-1 mediated apoptosis involves cytochrome c release from mitochondria
Ghosh, A. K., Majumder, M., Steele, R., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205384 · Cited by 20
Eick, D., Polack, A., Kofler, E., et al. (1988) · PubMed · Cited by 20
Lipp, M., Schilling, R., & Bernhardt, G. (1989) · PubMed · Cited by 20
Lee, H., Wu, M., Rosa, F. A. L., et al. (1995) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-79275-5_29 · Cited by 19
Activation of two discrete signaling pathways by erythropoietin.
Patel, H. R., Choi, H., & Sytkowski, A. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36607-4 · Cited by 19
Siebelt, F., Berberich, I., Shu, G. L., et al. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1198 · Cited by 19
Polack, A., Strobl, L. J., Feederle, R., et al. (1991) · PubMed · Cited by 19
Meulia, T., Krumm, A., Spencer, C., et al. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4590 · Cited by 19
Luo, Q., Li, J., Cenkci, B., & Kretzner, L. (2004) · Oncogene · doi:10.1038/sj.onc.1207225 · Cited by 18
Construction of a novel DNA decoy that inhibits the oncogenic β-catenin/T-cell factor pathway
Seki, Y., Yamamoto, H., Ngan, C. Y., Yasui, M., Tomita, N., Kitani, K., Takemasa, I., Ikeda, M., Sekimoto, M., Matsuura∥, N., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0388 · Cited by 18
Ishida, S., Shudo, K., Takada, S., & Koike, K. (1994) · PubMed · Cited by 18
The Max network: coordinated transcriptional regulation of cell growth and proliferation.
Eisenman, R. N. (2002) · PubMed · Cited by 18
Blake, M. C., Nikliński, J., & Zajac‐Kaye, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6060-6066.1996 · Cited by 17
Pharmacological inactivation of MYC for the treatment of cancer
Felsher, D. W., & Bradon, N. (2003) · Drug News & Perspectives · doi:10.1358/dnp.2003.16.6.829309 · Cited by 17
Imatinib mesylate—gold standards and silver linings
Peggs, K. S. (2004) · Clinical and Experimental Medicine · doi:10.1007/s10238-004-0032-5 · Cited by 17
Regulation of c-myc Transcription by Interleukin-2 (IL-2)
Grigorieva, I., Grigoriev, V. G., Rowney, M. K., & Hoover, R. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7343 · Cited by 17
Analysis of the c‐myc P2 promoter
Moberg, K. H., Tyndall, W. A., Pyrc, J. J., et al. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041480110 · Cited by 17
1,25-Dihydroxyvitamin D3-regulated binding of nuclear proteins to a c-myc intron element.
Pan, Q., Martell, R. E., O’Connell, T. D., et al. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828471 · Cited by 17
Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cells.
Baker, S. J., Pawlita, M., Leutz, A., et al. (1994) · PubMed · Cited by 17
Broome, H. E., Reed, J. C., Godillot, E. P., et al. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2988 · Cited by 17
White, R. A., Adkison, L. R., Dowler, L. L., et al. (1997) · Genomics · doi:10.1006/geno.1996.4499 · Cited by 16
A computerized database-scan to identify c-MYC targets
Schuldiner, O., Shor, S., & Benvenisty, N. (2002) · Gene · doi:10.1016/s0378-1119(02)00668-6 · Cited by 16
RAY, R., SHEIKH, S., Fontana, J. A., et al. (1994) · International Journal of Oncology · doi:10.3892/ijo.5.6.1433 · Cited by 16
The mechanism of inactivation of the normal c-myc gene locus in human Burkitt lymphoma cells.
Nishikura, K., & Jm, M. (1988) · PubMed · Cited by 16
A Novel Glucocorticoid Receptor Binding Element within the Murine c-myc Promoter
Ma, T., Copland, J. A., Brasier, A. R., et al. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.9.0524 · Cited by 15
Separate domains of MBP-1 involved in c-myc promoter binding and growth suppressive activity
Ray, R. B., & Steele, R. (1997) · Gene · doi:10.1016/s0378-1119(96)00693-2 · Cited by 15
Xiao, H., Tao, Y., & Roeder, R. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.3937 · Cited by 15
Kohlhuber, F., Lj, S., & Eick, D. (1993) · PubMed · Cited by 15
Mei, J. M., Hord, N. G., Winterstein, D., et al. (2000) · PubMed · Cited by 14
Ubiquitylation and Destruction of Endogenous c-MycS by the Proteasome: Are Myc Boxes Dispensable?
Chen, L., Smith, L., Accavitti-Loper, M. A., Ōmura, S., & Smith, J. B. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1603 · Cited by 14
Morgan, R., Pettengell, R., & Sohal, J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.002 · Cited by 14
Molecular Cloning and Expression Analysis of Five Novel Genes in Chromosome 1p36
Onyango, P. O., Lubyová, B., Gardellin, P., et al. (1998) · Genomics · doi:10.1006/geno.1997.5186 · Cited by 14
Frederick, J. P., & Wang, X. (2002) · Structure · doi:10.1016/s0969-2126(02)00914-0 · Cited by 14
Knockdown of MBP-1 in Human Prostate Cancer Cells Delays Cell Cycle Progression
Ghosh, A. K., Steele, R., & Ray, R. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602930200 · Cited by 14
No exit strategy? No problem: APC inhibits β-catenin inside the nucleus: Figure 1.Preprint
Xiong, Y., & Kotake, Y. (2006) · Genes & Development · doi:10.1101/gad.1413206 · Cited by 14
Savickienė, J., Gineitis, A. A., Vp, S., et al. (1995) · PubMed · Cited by 13
Dagnino, L., Zhu, L. W., Skorecki, K., et al. (1995) · PubMed · Cited by 13
Kawasaki, H., Machida, M., Komatsu, M., et al. (1996) · Artificial Organs · doi:10.1111/j.1525-1594.1996.tb04556.x · Cited by 12
Schneider, E. E., Albert, T., Wolf, D. A., et al. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60162-0_28 · Cited by 11
Regulatory domains within the P0 promoter of human c-myc.
Lang, J. C., Wilkie, N. M., Clark, A., et al. (1991) · PubMed · Cited by 11
Wierstra, I., & Alves, J. (2007) · Biological Chemistry · doi:10.1515/bc.2007.094 · Cited by 11
Self-citationFacchini, L. M., Chen, S., & Penn, L. Z. (1994) · PubMed · Cited by 11
Regulation of c-myc transcription initiation and elongation.
Snyder, R. C., & Miller, D. M. (1992) · PubMed · Cited by 11
Ray-Gallet, D., & Robert-Lézénès, J. (1989) · PubMed · Cited by 11
Hu, H., Arcinas, M., & Boxer, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111426200 · Cited by 10
A protein binding site from the murine c-myc promoter contributes to transcriptional block.
Dufort, D., Drolet, M., & Nepveu, A. (1993) · PubMed · Cited by 10
Positive and Negative Regulation of c-Myc Transcription
Zou, X., Lin, Y., Rudchenko, S., & Calame, K. L. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60801-8_5 · Cited by 9
Aoki, T., Imamura, T., OZAKI, H., et al. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60085 · Cited by 8
The Binding Mode of Human Nucleoside Diphosphate Kinase B to Single-Strand DNA
Agou, F., Raveh, S., & Véron, M. (2000) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1005593130867 · Cited by 7
c-myc Repression of Promoter Activity through Core Promoter Elements
Lucas, J. M., Wilkie, N. M., & Lang, J. C. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1987 · Cited by 6
Savickienė, J., Gineitis, A. A., Vp, S., et al. (1997) · PubMed · Cited by 6
ZAJAC-KAYE, M., Ben-Baruch, N., Kastanos, E. K., et al. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3450535 · Cited by 6
Novel DNase I Hypersensitive Sites in the 3′-Flanking Region of the Human c- myc Gene
Murphy, L. C., Huzel, N. J., & Davie, J. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.543 · Cited by 5
Editorial: Twists in the Tail—Change-of-Function Mutations in Thyroid Hormone Receptors
Forrest, D. (2002) · Endocrinology · doi:10.1210/endo.143.7.8964 · Cited by 5
Multiprotein complexes present at the MIF motifs flanking the promoter of the human c‐myc gene
Itkes, A. V., Allegra, C. J., & Zajac‐Kaye, M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01562-3 · Cited by 5
Old Livers: C/EBPa Meets New Partners
Timchenko, N. A. (2003) · Cell Cycle · doi:10.4161/cc.2.5.467 · Cited by 5
Carlberg, A. L., Moberg, K. H., & Hall, D. J. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.1.121 · Cited by 4
Bading, H., & Moelling, K. (1990) · PubMed · Cited by 3
Distinct mechanisms of c-myc and lymphokine gene expression in an antigen specific T cell clone.
Se, H., Gelmann, E. P., & Matis, L. A. (1988) · PubMed · Cited by 2
Research works printed but not linked: 3
- Bareket‐Samish, 2000, Signals for TBP/TATA‐box recognition, J. Mol. Biol., 299, 965
- Liu, 2006, Making Myc, Curr. Top. Microbiol. Immunol., 302, 1
- Skokowa, 2006, LEF‐1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia, Nat. Med., 12, 1191, 10.1038/nm1474 · DOI
Cited by
Sorted by citations
Duncan, J. S., Whittle, M. C., Nakamura, K., Abell, A. N., Midland, A. A., Zawistowski, J. S., Johnson, N. L., Granger, D. A., Jordan, N. V., Darr, D. B., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.053 · Cited by 732
MYC: Connecting selective transcriptional control to global RNA production
Kress, T. R., Sabò, A., & Amati, B. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3984 · Cited by 521
An Overview of MYC and Its Interactome
Conacci-Sorrell, M., McFerrin, L., & Eisenman, R. N. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014357 · Cited by 408
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396
Carabet, L. A., Rennie, P. S., & Cherkasov, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010120 · Cited by 172
“While being essential for normal Myc regulation in minimizing undesired Myc expression, the integrated biological output from the multiple-input signaling networks poses the risks of driving pathological conditions [33].”
BackgroundInfluential
Metadata
- Authors
- Wierstra, I., & Alves, J.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Inken Wierstra
- Venue
- Advances in Cancer Research
- Publisher
- Elsevier
- Published
- 2008
- Volume
- 99
- Pages
- 113-333
- ISSN
- 0065-230X (ISSN-L)
- OpenAlex
- W1870041030
- Cited by
- 211
- References
- 1,273
- Citations by year
- 2025: 6 · 2024: 5 · 2023: 9 · 2022: 8 · 2021: 9 · 2020: 18 · 2019: 12 · 2018: 11 · 2017: 16 · 2016: 11 · 2015: 9 · 2014: 12 · 2013: 17 · 2012: 13
- FWCI
- 15.49
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in cancer research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Keywords
- c-Myc, c-myc promoter, transcriptional regulation, chromatin structure, Burkitt lymphoma, proto-oncogenes, signaling pathways, transcription factors, cell cycle, terminal differentiation
- MeSH terms
- Proto-Oncogene Mas, Animals, Burkitt Lymphoma, Chromatin, Gene Expression Regulation, Humans, Neoplasms, Promoter Regions, Genetic, Proto-Oncogenes, Repressor Proteins, Transcription Factors, Signal Transduction, Genes, myc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review